Tipranavir: a novel second-generation nonpeptidic protease inhibitor (Q36066195)

12 August 2017

1 reference

title

Tipranavir: a novel second-generation nonpeptidic protease inhibitor (English)

1 reference

12 August 2017

author name string

Vijayabhaskar Reddy Kandula

series ordinal

1

1 reference

12 August 2017

Homayoun Khanlou

series ordinal

2

1 reference

12 August 2017

Charles Farthing

series ordinal

3

1 reference

12 August 2017

publication date

1 February 2005

1 reference

Expert Review of Anti-infective Therapy

12 August 2017

published in

1 reference

12 August 2017

volume

3

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

9-21

1 reference

Susceptibility to PNU-140690 (Tipranavir) of human immunodeficiency virus type 1 isolates derived from patients with multidrug resistance to other protease inhibitors

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.1.9

Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.1.9

Tipranavir inhibits broadly protease inhibitor-resistant HIV-1 clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.1.9

A 14-day dose-response study of the efficacy, safety, and pharmacokinetics of the nonpeptidic protease inhibitor tipranavir in treatment-naive HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.1.9

21 January 2018

Identifiers

DOI

10.1586/14787210.3.1.9

1 reference

12 August 2017

1 reference